AdvtAdvtJoin the community of 2M+ industry professionals. Subscribe to Newsletter to get latest insights & analysis in your inbox. Download the ETPharma App and get the Realtime updates and Save your favourite articles. His tenure included a series of high-profile disputes over product reviews for vaccines, including Moderna's COVID shot, gene therapies and other rare disease drugs.He was ​appointed as the director of the FDA's Center for Biologics Evaluation and ⁠Research in ‌May last year. (Reporting by Christy Santhosh and Kamal Choudhury in Bengaluru; Michael Erman in New York; Editing by Sriraj Kalluvila, Shinjini Ganguli, and Caroline Humer)>

Source: Economic Times March 07, 2026 02:46 UTC